Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00084487
Status:
TERMINATED
Last Update Posted:
2014-05-23
First Post:
2004-06-10
Brief Title:
Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy
Sponsor:
Organization:
National Cancer Institute NCI